Stock Screener App

Gratuito -

Installare

123.34

2.71% 3.18

Incyte Corp (INCY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Incyte Corp Borsa (INCY) Ultime notizie

Global Vitiligo Foundation Applauds Incyte’s "Moments of Clarity" Campaign for Elevating Patient Voices and Advancing Vitiligo Awareness - Yahoo Finance

Incyte stock holds at the $120 mark as strong quarterly earnings support valuation - ad-hoc-news.de

Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup - ChartMill

State of Wyoming Acquires New Holdings in Incyte Corporation $INCY - MarketBeat

LTS:0J9P EV-to-OCF: 10.03 — 48% Below Median - GuruFocus

55,370 Shares in Incyte Corporation $INCY Bought by Summit Global Investments - MarketBeat

Baird Chautauqua Global Growth Fund's Incyte Corp(INCY) Holding History - GuruFocus

Incyte Corp's Pablo J. Cagnoni Sells 10,803 Shares Under Rule 10b5-1 Plan in August 2026 - Kalkine Media

Incyte Corp (INCY) R&D chief sells 10,803 shares under Rule 10b5-1 plan - Stock Titan

Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics? - Yahoo Finance

Incyte stock gains support as Q2 2026 sales surge and guidance rises - AD HOC NEWS

Incyte Sales Growth Drives Share Price Gains - FXEmpire

Insight Wealth Strategies LLC Acquires New Position in Incyte Corporation $INCY - MarketBeat

Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus

Incyte Corp (HAM:ICY) Stock Price, Trades & News - GuruFocus

Incyte Corporation (NASDAQ:INCY): What Could Drive Shares Next? - Kalkine Media

Incyte (INCY) Short Interest & Short Float | Updated Aug 2026 $INCY - MarketBeat

Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Bank of America Corp DE Sells 87,913 Shares of Incyte Corporation $INCY - MarketBeat

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Finviz

Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch

Incyte Corp (INCY) R&D head sells 10,640 shares in plan trade - Stock Titan

Incyte Corp (INCY) EVP sells 2,207 shares after option exercise - Stock Titan

Incyte Corp (ICY.HA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch

Incyte (NASDAQ:INCY) EVP Sells $5,005,254.54 in Stock - MarketBeat

Incyte Corp (INCY) R&D head sells 15,888 shares, retains 215,444 - Stock Titan

Incyte Corp (INCY) EVP sells 47,954 shares after exercising options - Stock Titan

Quantinno Capital Management LP Raises Position in Incyte Corporation $INCY - MarketBeat

The Manufacturers Life Insurance Company Sells 30,324 Shares of Incyte Corporation $INCY - MarketBeat

H.C. Wainwright reiterates Incyte stock rating on JAK inhibitor data - Investing.com

Amundi Purchases 229,783 Shares of Incyte Corporation $INCY - MarketBeat

Incyte (INCY) Won EU Approval For Opzelura, Has The Market Already Priced It In? - Yahoo Finance

Incyte (INCY) Stock Trades Reasonable On Earnings While Returns Look Strong - Yahoo Finance

Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch

Incyte Corporation (INCY) Stock Forecasts - Yahoo Finance

Incyte Corporation $INCY Shares Acquired by Edgestream Partners L.P. - MarketBeat

Incyte Earnings: Opzelura Settlement and Latarcibart Improve Outlook Ahead of Jakafi Patent Loss - Morningstar

No-Moat Incyte Faces Jakafi Patent Cliff as Focus Remains on Opzelura and Expanding Portfolio - Morningstar

Incyte Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results - Benzinga

Incyte lifts annual revenue forecast after settlement with CMS - pharma.economictimes.indiatimes.com

Incyte Corporation (INCY) Q2 2026 Earnings Call Transcript - AlphaStreet

Incyte stock jumps after Q2 beat and sharply higher 2026 sales outlook - Quiver Quantitative

A Noteworthy Decision By Lee Heeson As Acquires $130K In Incyte Stock Options - Benzinga

James Michael Morrissey Expands Holdings With $54K Incyte Stock Options Acquisition - Benzinga

Incyte Q2 Earnings Call Highlights - Yahoo Finance

INCY Looks 18.3% Overvalued on GF Value™ as Growth Momentum Rema - GuruFocus

Earnings call transcript: Incyte Q2 2026 beats forecasts, lifts guidance - Investing.com

Incyte Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Incyte Q2 Results: Adj. EPS $3.09 Beats Estimate, Sales Rise 37% - scanx.trade

INCY Looks 18.4% Overvalued on GF Value™ as of July 28, 2026 - GuruFocus

Incyte (INCY) Q2 Earnings and Revenues Top Estimates - Yahoo Finance Australia

INCY Looks 18.4% Overvalued on GF Value™ - GuruFocus

INCY Looks 18.4% Overvalued on GF Value™ as Growth Outlook Stren - GuruFocus

Is Incyte Corp (INCY) Worth the Current Valuation After Q2 Earni - GuruFocus

Incyte beats Q2 estimates but stock dips slightly on lowered guidance By Investing.com - Investing.com South Africa

Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly - Yahoo Finance

Incyte earnings beat by $1.10, revenue topped estimates - Investing.com

Incyte: Q2 Earnings Snapshot - KING5.com

Incyte Revenue Rises 38 Percent to $1.67 Billion in Q2 - Quiver Quantitative

MRNA

$65.16

3.02%

ROIV

$36.27

0.46%

RPRX

$59.20

0.97%

INSM

$126.74

2.37%

ALNY

$224.78

1.90%

ONC

$360.35

3.72%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters